- Home
- NAUT vs VMD Comparison
NAUT vs VMD Comparison
Compare NAUT & VMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NAUT | VMD |
|---|---|---|
| Founded | 2016 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 125.4M | 465.4M |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | NAUT | VMD |
|---|---|---|
| Price | $0.88 | $9.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 828.6K | 409.6K |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 16.07 | ★ 32.14 |
| EPS | N/A | ★ 0.13 |
| Revenue | N/A | ★ $270,280,000.00 |
| Revenue This Year | N/A | $17.88 |
| Revenue Next Year | $992.86 | $14.98 |
| P/E Ratio | ★ N/A | $69.62 |
| Revenue Growth | N/A | ★ 20.52 |
| 52 Week Low | $0.62 | $6.05 |
| 52 Week High | $4.31 | $12.61 |
Technical Indicators
Market Signals| Indicator | NAUT | VMD |
|---|---|---|
| Relative Strength Index (RSI) | 22.77 | 25.61 |
| Support Level | $0.84 | $8.03 |
| Resistance Level | $2.30 | $10.05 |
| Average True Range (ATR) | 0.07 | 0.38 |
| MACD | 0.02 | -0.16 |
| Stochastic Oscillator | 14.90 | 4.42 |
Price Performance
Historical ComparisonAbout NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
About VMD Viemed Healthcare Inc.
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.